Fosun Pharma signs exclusive license agreement with Shanghai Henlius Biotech

MLA

“Fosun Pharma Signs Exclusive License Agreement with Shanghai Henlius Biotech.” M2 EquityBites (EQB), 9 Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.732656840&authtype=sso&custid=ns315887.

APA

Fosun Pharma signs exclusive license agreement with Shanghai Henlius Biotech. (2023, January 9). M2 EquityBites (EQB).

Chicago

M2 EquityBites (EQB). 2023. “Fosun Pharma Signs Exclusive License Agreement with Shanghai Henlius Biotech,” January 9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.732656840&authtype=sso&custid=ns315887.